Pharmaceutical stocks, which were lying low bounced back this past week with second quarter results largely in line with analyst expectations on recovery of domestic formulation business after disruption caused due to GST transition in the first quarter. Torrent Pharmaceuticals' acquisition of Indian branded business of Unichem Laboratories and USFDA lifting import ban on Divis Laboratories' Unit-II in Visakhapatnam are highlights of the week.

Pharmaceutical stocks, which were lying low bounced back this past week with second quarter results largely in line with analyst expectations on recovery of domestic formulation business after disruption caused due to GST transition in the first quarter. Torrent Pharmaceuticals' acquisition of Indian branded business of Unichem Laboratories and USFDA lifting import ban on Divis Laboratories' Unit-II in Visakhapatnam are highlights of the week.